Peginterferon - SCH 503034 Jumps on the Fast Track

SCH 503034 Jumps on the Fast Track
Schering-Plough's oral HCV protease inhibitor, SCH 503034, is in phase II trials, and may make for a better combination with Peg-intron. Check-in with us regularly, as we will be keeping close tabs on this development....

Primary Biliary Cirrhosis
Title: Primary Biliary CirrhosisCategory: Diseases and ConditionsCreated: 12/31/1997Last Editorial Review: 9/17/2005

Tattoos don t disrupt order
shared by mfeed Muskogee Daily Phoenix - The Oklahoma Legislature this session will undoubtedly pass a bill permitting tattoo parlors in the state. A House committee sent a bill to the House floor earlier this week, and language between the House and Senate versions will have to be worked ...... Read more... blink it

Hepatitis C
Title: Hepatitis CCategory: Diseases and ConditionsCreated: 12/31/1997Last Editorial Review: 9/17/2005

Ultrasound
Title: UltrasoundCategory: Procedures and TestsCreated: 12/31/1997Last Editorial Review: 10/15/2005

Shorter Therapy Effective for Genotypes 2 and 3
Genotypes 2 and 3 are much more responsive to current interferon combination therapies. This report details studies that show a shorter course of treatment might be just as effective as longer courses. Researchers continue to refine treatment protocols for HCV...